| Literature DB >> 30023710 |
Haresh Ajani1,2, Adam Pecina1, Saltuk M Eyrilmez1,2, Jindřich Fanfrlík1, Susanta Haldar1, Jan Řezáč1, Pavel Hobza1,3, Martin Lepšík1.
Abstract
General and reliable description of structures and energetics in protein-ligand (PL) binding using the docking/scoring methodology has until now been elusive. We address this urgent deficiency of scoring functions (SFs) by the systematic development of corrected semiempirical quantum mechanical (SQM) methods, which correctly describe all types of noncovalent interactions and are fast enough to treat systems of thousands of atoms. Two most accurate SQM methods, PM6-D3H4X and SCC-DFTB3-D3H4X, are coupled with the conductor-like screening model (COSMO) implicit solvation model in so-called "SQM/COSMO" SFs and have shown unique recognition of native ligand poses in cognate docking in four challenging PL systems, including metalloprotein. Here, we apply the two SQM/COSMO SFs to 17 diverse PL complexes and compare their performance with four widely used classical SFs (Glide XP, AutoDock4, AutoDock Vina, and UCSF Dock). We observe superior performance of the SQM/COSMO SFs and identify challenging systems. This method, due to its generality, comparability across the chemical space, and lack of need for any system-specific parameters, gives promise of becoming, after comprehensive large-scale testing in the near future, a useful computational tool in structure-based drug design and serving as a reference method for the development of other SFs.Entities:
Year: 2017 PMID: 30023710 PMCID: PMC6044937 DOI: 10.1021/acsomega.7b00503
Source DB: PubMed Journal: ACS Omega ISSN: 2470-1343
Figure 1Number of HFP solutions for the six SFs used here across all the 17 PL systems studied. (A) Number of HFPs and (B) HFPs for individual PL complexes sorted by ligand charge: neutral (left) and charged (right).
Figure 2Two-dimensional structures of the ligands studied.
Summary of the 17 PL Complexes Studied
| PDB code | resolution (Å) | protein name | class | ligand charge | rotatable bonds in ligand |
|---|---|---|---|---|---|
| 2FVD | 1.8 | CDK2 | transferase (E.C.2) | 0 | 6 |
| 10GS | 2.2 | glutathione | –1 | 13 | |
| 3PE2 | 1.9 | casein kinase IIα | –1 | 4 | |
| 3GCU | 2.1 | mitogen-activated protein kinase 14 | 0 | 6 | |
| 2OBF | 2.3 | phenylethanolamine | +1 | 4 | |
| 3JVS | 1.9 | checkpoint kinase 1 | –1 | 5 | |
| 3GNW | 2.4 | hepatitis C virus NS5B RNA-dependent RNA polymerase | 0 | 5 | |
| 2CET | 1.9 | β-glucosidase A | hydrolase (E.C.3) | +1 | 4 |
| 4GID | 2.0 | β-secretase I | +1 | 16 | |
| 2ZX6 | 2.4 | α- | +1 | 4 | |
| 3NOX | 2.3 | dipeptidyl peptidase 4 | +1 | 3 | |
| 2VOT | 1.9 | β-mannosidase | +1 | 4 | |
| 2XB8 | 2.4 | 3-dehydroquinate dehydratase | lyase (E.C.4) | –1 | 4 |
| 2VW5 | 1.9 | heat shock protein Hsp82 | chaperone | 0 | 3 |
| 2YKI | 1.6 | heat shock protein Hsp90-α | 0 | 3 | |
| 2P4Y | 2.2 | peroxisome proliferator-activated receptor γ | nuclear receptor | –1 | 9 |
| 3G0W | 1.9 | androgen receptor | 0 | 2 |